ijms-logo

Journal Browser

Journal Browser

Targeted Therapy of Cancer: Innovative Drugs and Molecular Tools

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 30 May 2025

Special Issue Editors


E-Mail Website
Guest Editor
Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy
Interests: drug delivery; toxins; immune conjugates; cancer therapy; protein structure; protein toxins; immunotoxins; endocytosis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Life, Health and Environmental Sciences, University of L’Aquila. Piazzale Salvatore Tommasi 1, 67100 Coppito (AQ) and Interuniversity Consortium Biostructures and Biosystems National Institute (INBB), 00136 Rome, Italy.
Interests: transferrins; lactoferrin; ovotransferrin; saporin; ADCs
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Modern medicine has focused its attention on the possibility of delivering drugs in a controlled manner, particularly as soon as more attractive targets have emerged, and new molecular tools have become available. Targeted cancer therapy has become an innovative strategy, with new drugs being constantly discovered and applied in the treatment of various types of tumors, enabling precision and personalized medicine. A major challenge concerns the safe delivery of drugs (minimizing side-effects) and the potential exploitation of novel molecular tools, such as miRNA, CRISPR-Cas9, aptamers, and EVs. These approaches complement the use of more classical methods, such as antibody-based therapies, which still require innovation to become more effective.

This Special Issue of the International Journal of Molecular Sciences aims to focus on the use of innovative drugs and molecular tools to target cancer cells in vivo, with particular attention to the mechanisms of action and the structural characteristics of novel therapeutic agents. We look forward to exploring all aspects of recent applications of cancer-targeted agents and biomaterials for controlled drug release. Contributions in the form of original research articles and reviews, focusing on the rational design, synthesis, and/or biological evaluation of various agents (including small molecules, nano-drugs, natural products, endogenous molecules, antibodies, vaccines, etc.) as potential cancer therapeutics, are welcome for submission to this Special Issue.

 

Prof. Dr. Rodolfo Ippoliti
Dr. Francesco Giansanti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug delivery
  • targeted therapies
  • cancer therapy
  • molecular targets
  • precision medicine
  • molecular therapeutic targets

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop